Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Accumulated Expenses (2016 - 2025)

AtriCure (ATRC) has disclosed Accumulated Expenses for 16 consecutive years, with $53.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Accumulated Expenses rose 16.46% to $53.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $53.1 million, a 16.46% increase, with the full-year FY2025 number at $53.1 million, up 16.46% from a year prior.
  • Accumulated Expenses was $53.1 million for Q4 2025 at AtriCure, up from $49.4 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $53.1 million in Q4 2025 to a low of $7.5 million in Q1 2021.
  • A 5-year average of $34.4 million and a median of $32.5 million in 2022 define the central range for Accumulated Expenses.
  • Biggest YoY gain for Accumulated Expenses was 5361.82% in 2021; the steepest drop was 58.56% in 2021.
  • AtriCure's Accumulated Expenses stood at $36.1 million in 2021, then dropped by 8.51% to $33.0 million in 2022, then surged by 35.31% to $44.7 million in 2023, then increased by 2.03% to $45.6 million in 2024, then rose by 16.46% to $53.1 million in 2025.
  • Per Business Quant, the three most recent readings for ATRC's Accumulated Expenses are $53.1 million (Q4 2025), $49.4 million (Q3 2025), and $40.3 million (Q2 2025).